Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2016
Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine TumorsEmmanouil Panagiotidis, Alshaima Alshammari, Sofia Michopoulou, et al.Neuroendocrinology|June 6, 2015
Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver MetastasesStefano Partelli, Marco Inama, Anja Rinke, et al.Pancreas|May 3, 2021
High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective AnalysisAimee R Hayes, Myles Furnace, Ruchir Shah, et al.Pancreas|July 29, 2010
The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and CecumJ Philip Boudreaux, David S Klimstra, Manal M Hassan, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 27, 2016
Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational studyPhilippe Ruszniewski, Juan W Valle, Catherine Lombard-Bohas, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United KingdomEvangelia Skoura, Sofia Michopoulou, Mullan Mohmaduvesh, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomasDamian Wild, Emanuel Christ, Martyn E Caplin, et al.Endocrine-Related Cancer|April 20, 2026
Unravelling Mesenteric Fibrosis in Small Intestinal Neuroendocrine Tumours and Implications for Clinical ManagementMaria Castanho Martins, Eva van der Slik, Johannes Hofland, et al.Journal of the American College of Cardiology|March 11, 2017
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert StatementJoseph Davar, Heidi M Connolly, Martyn E Caplin, et al.The New England Journal of Medicine|July 12, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumorsMartyn E Caplin, Marianne Pavel, Jarosław B Ćwikła, et al.Pageof 8